Annual Statements Open main menu

STANDEX INTERNATIONAL CORP/DE/ - Quarter Report: 2021 September (Form 10-Q)

sxi20210930_10q.htm
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 

☒     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2021

 

☐    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number 001-07233

 

STANDEX INTERNATIONAL CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware

 

31-0596149

(State of incorporation)

(IRS Employer Identification No.)

 

23 Keewaydin Drive, Salem, New Hampshire

03079

(Address of principal executive offices)

(Zip Code)

 

(603) 893-9701

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, Par Value $1.50 Per Share

SXI

New York Stock Exchange

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☒

 

 

Accelerated filer ☐

 

Non-accelerated filer ☐  

Smaller reporting company ☐

 

   

Emerging growth company ☐

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes ☐    No ☒

 

The number of shares of Registrant's Common Stock outstanding on November 2, 2021 was 12,210,402.

 

1

 

 

 

STANDEX INTERNATIONAL CORPORATION

 

 

INDEX

 

 

 

 

Page No.

PART I.  FINANCIAL INFORMATION:

 

 

 

 

Item 1.

 

 

 

 

 

 

Condensed Consolidated Balance Sheets as of September 30, 2021 and June 30, 2021 (unaudited)

3

 

 

 

 

Condensed Consolidated Statements of Operations for the three months ended September 30, 2021 and 2020 (unaudited)

4

 

 

 

 

Condensed Consolidated Statements of Comprehensive Income (Loss) for the three months ended September 30, 2021 and 2020 (unaudited)

5

 

 

 

 

Condensed Consolidated Statement of Stockholders’ Equity for the three months ended September 30, 2021 and 2020 (unaudited)

6

 

 

 

 

Condensed Consolidated Statements of Cash Flows for the three months ended September 30, 2021 and 2020 (unaudited)

7

 

 

 

 

Notes to Unaudited Condensed Consolidated Financial Statements

8

 

 

 

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

22

 

 

 

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

32

 

 

 

Item 4.

Controls and Procedures

33

 

 

 

PART II.  OTHER INFORMATION:

 

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

34

     

Item 6.

Exhibits

35

 

2

 

 

 

PART I. FINANCIAL INFORMATION

ITEM 1

 

STANDEX INTERNATIONAL CORPORATION

Unaudited Condensed Consolidated Balance Sheets

 

(In thousands, except per share data)

 

September 30, 2021

  

June 30, 2021

 

ASSETS

        

Current Assets:

        

Cash and cash equivalents

 $130,683  $136,367 

Accounts receivable, less allowance for credit losses of $1,933 and $1,588 at September 30, 2021 and June 30, 2021, respectively

  105,435   109,883 

Inventories

  100,082   91,862 

Prepaid expenses and other current assets

  27,844   23,504 

Income taxes receivable

  12,273   12,750 

Total current assets

  376,317   374,366 
         

Property, plant, and equipment, net

  131,813   133,373 

Intangible assets, net

  96,416   98,929 

Goodwill

  276,908   278,054 

Deferred tax asset

  9,105   9,566 

Operating lease right-of-use asset

  38,803   37,276 

Other non-current assets

  31,280   30,659 

Total non-current assets

  584,325   587,857 
         

Total assets

 $960,642  $962,223 
         

LIABILITIES AND STOCKHOLDERS' EQUITY

        

Current Liabilities:

        

Accounts payable

 $79,475  $74,756 

Accrued liabilities

  50,567   61,717 

Income taxes payable

  5,128   7,236 

Total current liabilities

  135,170   143,709 
         

Long-term debt

  199,575   199,490 

Operating lease long-term liabilities

  30,825   29,041 

Accrued pension and other non-current liabilities

  82,342   83,558 

Total non-current liabilities

  312,742   312,089 
         

Contingencies (Note 15)

          
         

Stockholders' equity:

        

Common stock, par value $1.50 per share, 60,000,000 shares authorized, 27,984,278 shares issued, 12,027,267 and 12,044,405 shares outstanding at September 30, 2021 and June 30, 2021

  41,976   41,976 

Additional paid-in capital

  82,065   80,788 

Retained earnings

  865,355   852,489 

Accumulated other comprehensive loss

  (116,266)  (116,140)

Treasury shares: 15,957,011 and 15,939,873 shares at September 30, 2021 and June 30, 2021

  (360,400)  (352,688)

Total stockholders' equity

  512,730   506,425 
         

Total liabilities and stockholders' equity

 $960,642  $962,223 

 

See notes to unaudited condensed consolidated financial statements 

3

 
 

STANDEX INTERNATIONAL CORPORATION

Unaudited Condensed Consolidated Statements of Operations

 

  

Three Months Ended

 
  

September 30,

 

(In thousands, except per share data)

 

2021

  

2020

 

Net sales

 $175,610  $151,286 

Cost of sales

  109,373   96,550 

Gross profit

  66,237   54,736 

Selling, general, and administrative expenses

  42,752   38,869 

Restructuring costs

  440   1,488 

Acquisition related costs

  217   25 

Total operating expenses

  43,409   40,382 

Income from operations

  22,828   14,354 

Interest expense

  1,720   1,484 

Other non-operating (income) expense, net

  23   (173)

Income from continuing operations before income taxes

  21,085   13,043 

Provision for income taxes

  5,264   2,696 

Income from continuing operations

  15,821   10,347 

Income (loss) from discontinued operations, net of tax

  (3)  (627)

Net income

 $15,818  $9,720 
         

Basic earnings (loss) per share:

        

Continuing operations

 $1.32  $0.85 

Discontinued operations

  -   (0.05)

Total

 $1.32  $0.80 

Diluted earnings (loss) per share:

        

Continuing operations

 $1.30  $0.84 

Discontinued operations

  -   (0.05)

Total

 $1.30  $0.79 
         

Weighted average number of shares:

        

Basic

  12,023   12,228 

Diluted

  12,149   12,281 

 

See notes to unaudited condensed consolidated financial statements 

 

4

 
 

STANDEX INTERNATIONAL CORPORATION 

Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss)

 

  

Three Months Ended

 
  

September 30,

 

(In thousands)

 

2021

  

2020

 

Net income

 $15,818  $9,720 

Other comprehensive income (loss):

        

Defined benefit pension plans:

        

Actuarial gains (losses) and other changes in unrecognized costs, net of tax

 $85  $(169)

Amortization of unrecognized costs, net of tax

  1,112   1,267 

Derivative instruments:

        

Change in unrealized gains (losses), net of tax

  158   (458)

Amortization of unrealized gains (losses) into interest expense, net of tax

  935   450 

Foreign currency translation gains (losses), net of tax

  (2,416)  9,518 

Other comprehensive income (loss), net of tax

 $(126) $10,608 

Comprehensive income

 $15,692  $20,328 

 

See notes to unaudited condensed consolidated financial statements 

 

5

 
 

STANDEX INTERNATIONAL CORPORATION AND SUBSIDIARIES 

Unaudited Consolidated Statements of Stockholders' Equity 

 

              

Accumulated Other

             
      

Additional

      

Comprehensive

          

Total

 

For the Three month period ended September 30, 2021

 

Common

  

Paid-in

  

Retained

  

Income

  

Treasury Stock

  

Stockholders’

 

(in thousands, except as specified)

 

Stock

  

Capital

  

Earnings

  

(Loss)

  

Shares

  

Amount

  

Equity

 

Balance, June 30, 2021

 $41,976  $80,788  $852,489  $(116,140)  15,940  $(352,688) $506,425 

Stock issued under incentive compensation plans and employee purchase plans

  -   (812)  -   -   (80)  1,788   976 

Stock-based compensation

  -   2,089   -   -   -   -   2,089 

Treasury stock acquired

  -   -   -   -   97   (9,500)  (9,500)

Comprehensive income:

                            

Net income

  -   -   15,818   -   -   -   15,818 

Foreign currency translation adjustment

  -   -   -   (2,416)  -   -   (2,416)

Pension, net of tax of $0.4 million

  -   -   -   1,197   -   -   1,197 

Change in fair value of derivatives, net of tax of $0.1 million

  -   -   -   1,093   -   -   1,093 

Dividends declared ($0.24 per share)

  -   -   (2,952)  -   -   -   (2,952)

Balance, September 30, 2021

 $41,976  $82,065  $865,355  $(116,266)  15,957  $(360,400) $512,730 
                             

For the Three month period ended September 30, 2020

                            

(in thousands, except as specified)

                            

Balance, June 30, 2020

 $41,976  $72,752  $827,656  $(147,659)  15,748  $(333,093) $461,632 

Stock issued under incentive compensation plans and employee purchase plans

  -   (472)  -   -   (55)  1,165   693 

Stock-based compensation

  -   1,755   -   -   -   -   1,755 

Treasury stock acquired

  -   -   -   -   87   (5,109)  (5,109)

Comprehensive income:

                            

Net income

  -   -   9,720   -   -   -   9,720 

Foreign currency translation adjustment

  -   -   -   9,518   -   -   9,518 

Pension, net of tax of $0.4 million

  -   -   -   1,098   -   -   1,098 

Change in fair value of derivatives, net of tax of $0 million

  -   -   -   (8)  -   -   (8)

Dividends declared ($0.22 per share)

  -   -   (2,731)  -   -   -   (2,731)

Balance, September 30, 2020

 $41,976  $74,035  $834,645  $(137,051)  15,780  $(337,037) $476,568 

 

6

 
 

STANDEX INTERNATIONAL CORPORATION

 Unaudited Condensed Consolidated Statements of Cash Flows

 

  

Three Months Ended

 
  

September 30,

 

(In thousands)

 

2021

  

2020

 

Cash flows from operating activities

        

Net income

 $15,818  $9,720 

Income (loss) from discontinued operations

  (3)  (627)

Income from continuing operations

  15,821   10,347 

Adjustments to reconcile net income to net cash provided by (used in) operating activities:

        

Depreciation and amortization

  7,725   8,193 

Stock-based compensation

  2,089   1,755 

Non-cash portion of restructuring charge

  (49)  (414)

Contributions to defined benefit plans

  (52)  (52)

Changes in operating assets and liabilities, net

  (12,448)  (10,595)

Net cash provided by operating activities - continuing operations

  13,086   9,234 

Net cash provided by (used in) operating activities - discontinued operations

  (15)  2,190 

Net cash provided by operating activities

  13,071   11,424 

Cash flows from investing activities

        

Expenditures for property, plant, and equipment

  (5,022)  (4,820)

Expenditures for acquisitions, net of cash acquired

  -   (27,398)

Other investing activity

  (31)  199 

Net cash provided by (used in) investing activities

  (5,053)  (32,019)

Cash flows from financing activities

        

Proceeds from borrowings

  -   16,500 

Payments of debt

  -   (16,500)

Contingent consideration payment

  (1,167)  - 

Activity under share-based payment plans

  976   693 

Purchases of treasury stock

  (9,500)  (5,109)

Cash dividends paid

  (2,890)  (2,692)

Net cash provided by (used in) financing activities

  (12,581)  (7,108)

Effect of exchange rate changes on cash and cash equivalents

  (1,121)  2,592 

Net change in cash and cash equivalents

  (5,684)  (25,111)

Cash and cash equivalents at beginning of year

  136,367   118,809 

Cash and cash equivalents at end of period

 $130,683  $93,698 
         

Supplemental Disclosure of Cash Flow Information:

        

Cash paid during the year for:

        

Interest

 $1,269  $1,225 

Income taxes, net of refunds

 $6,622  $5,753 

 

See notes to unaudited condensed consolidated financial statements

 

7

 

 

STANDEX INTERNATIONAL CORPORATION

Notes to Unaudited Condensed Consolidated Financial Statements

 

 

1)     Management Statement

 

In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the results of operations for the three months ended September 30, 2021 and 2020, the cash flows for the three months ended September 30, 2021 and 2020 and the financial position of Standex International Corporation (“Standex”, the “Company”, “we”, “us”, or “our”), at September 30, 2021. The interim results are not necessarily indicative of results for a full year. The following unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and note disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although the company believes that the disclosures made are adequate to make the information not misleading. The unaudited condensed consolidated financial statements and notes do not contain information which would substantially duplicate the disclosures contained in the audited annual consolidated financial statements and notes for the year ended June 30, 2021. The condensed consolidated balance sheet at June 30, 2021 was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. The financial statements contained herein should be read in conjunction with the Annual Report on Form 10-K and in particular the audited consolidated financial statements for the year ended June 30, 2021. Unless otherwise noted, references to years are to the Company’s fiscal years. Currently our fiscal year end is June 30.  For further clarity, our fiscal year 2022 includes the twelve-month period from July 1, 2021 to June 30, 2022.

 

The estimates and assumptions used in the preparation of the consolidated financial statements have considered the implications on the Company as a result of the COVID-19 pandemic and its related economic impacts. As a result of the COVID-19 pandemic,  there is heightened volatility and uncertainty in customer demand and the worldwide economy. However, the magnitude of such impact on the Company’s business and its duration is uncertain. The Company is not aware of any specific event or circumstance that would require an update to its estimates or adjustments to the carrying value of its assets and liabilities as of  September 30, 2021 and the issuance date of the Quarterly Report on Form 10-Q.

 

The Company considers events or transactions that occur after the balance sheet date but before the financial statements are issued to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. The Company evaluated subsequent events through the date and time its unaudited condensed consolidated financial statements were issued. 

 

Recently Issued Accounting Pronouncements

 

There were no recently issued accounting pronouncements which are expected to have a material impact on the consolidated financial statements. 

 

 

2)     Acquisitions

 

The Company's recent acquisitions are strategically significant to the future growth prospects of the Company. At the time of the acquisition and September 30, 2021, the Company evaluated the significance of each acquisition on a standalone basis and in aggregate, considering both qualitative and quantitative factors.

 

During the first quarter of fiscal year 2021, the Company acquired Renco Electronics, a designer and manufacturer of customized standard magnetics components and products including transformers, inductors, chokes and coils for power and RF applications.  Renco’s end markets and customer base in areas such as consumer and industrial applications are highly complementary to our existing business with the potential to further expand key account relationships and capitalize on cross selling opportunities between the two companies.  Renco operates one manufacturing facility in Florida and is supported by contract manufacturers in Asia. Renco’s results are reported within our Electronics segment.

 

The Company paid $27.4 million in cash for all of the issued and outstanding equity interests of Renco Electronics. The purchase price was allocated to the net tangible and identifiable intangible assets acquired and liabilities assumed based on a valuation of their fair values on the closing date. Goodwill recorded from this transaction is attributable to Renco’s significant engineering and technical expertise in end markets supported by strong engineer-to-engineer relationships. In addition, Renco’s end markets and customer base in areas such as consumer and industrial are highly complementary to the Company’s existing business.

 

8

 

Intangible assets of $10.4 million consist primarily of $3.6 million for indefinite lived tradenames, and $6.8 million of customer relationships to be amortized over 12 years. The goodwill of $14.0 million created by the transaction is deductible for income tax purposes. The accounting for business combinations requires estimates and judgments regarding expectations for future cash flows of the acquired business, and the allocations of those cash flows to identifiable tangible and intangible assets, in determining the assets acquired and liabilities assumed. The fair values assigned to tangible and intangible assets acquired and liabilities assumed, including contingent consideration, are based on management’s best estimates and assumptions, as well as other information compiled by management, including valuations that utilize customary valuation procedures and techniques. 

 

The components of the fair value of the Renco Electronics acquisition, including the final allocation of the purchase price are as follows (in thousands):

 

  

Preliminary Allocation September 30, 2020

  

Adjustments

  

Final Allocation

 

Fair value of business combination:

            

Cash payments

 $29,530  $83  $29,613 

Less, cash acquired

  (2,132)  (75)  (2,207)

Fair value of contingent consideration

  3,000   -   3,000 

Total

 $30,398  $8  $30,406 

 

 

  

Preliminary Allocation September 30, 2020

  

Adjustments

  

Final Allocation

 

Identifiable assets acquired and liabilities assumed:

            

Other acquired assets

 $4,762  $(240) $4,522 

Inventories

  5,446   -   5,446 

Property, plant, & equipment

  -   410   410 

Identifiable intangible assets

  10,400   -   10,400 

Goodwill

  14,153   (162)  13,991 

Debt assumed

  (712)  -   (712)

Liabilities assumed

  (3,651)  -   (3,651)

Total

 $30,398  $8  $30,406 

 

Acquisition Related Costs

 

Acquisition related costs include costs related to acquired businesses and other pending acquisitions. These costs consist of (i) deferred compensation arrangements and (ii) acquisition related professional service fees and expenses, including financial advisory, legal, accounting, and other outside services incurred in connection with acquisition activities, and regulatory matters related to acquired entities. These costs do not include purchase accounting expenses, which we define as acquired backlog and the step-up of inventory to fair value, or the amortization of the acquired intangible assets.

 

The components of acquisition related costs are as follows (in thousands):

 

  

Three Months Ended

 
  

September 30,

 
  

2021

  

2020

 

Other acquisition related costs

 $217  $25 

Total

 $217  $25 

 

9

 
 

3)     Revenue From Contracts With Customers

 

Most of the Company’s contracts have a single performance obligation which represents the product or service being sold to the customer. Some contracts include multiple performance obligations such as a product and the related installation and/or extended warranty. Additionally, most of the Company’s contracts offer assurance type warranties in connection with the sale of a product to customers. Assurance type warranties provide a customer with assurance that the product complies with agreed-upon specifications. Assurance type warranties do not represent a separate performance obligation.

 

In general, the Company recognizes revenue at the point in time control transfers to its customer based on predetermined shipping terms. Revenue is recognized over time under certain long-term contracts within the Engineering Technologies and Engraving groups for highly customized customer products that have no alternative use and in which the contract specifies the Company has a right to payment for its costs, plus a reasonable margin. For products manufactured over time, the transfer of control is measured pro rata, based upon current estimates of costs to complete such contracts. Losses on contracts are fully recognized in the period in which the losses become determinable. Revisions in profit estimates are reflected on a cumulative basis in the period in which the basis for such revision becomes known.

 

Disaggregation of Revenue from Contracts with Customers

 

The following table presents revenue disaggregated by product line and segment (in thousands):

 

  

Three Months Ended

 

Revenue by Product Line

 

September 30, 2021

  

September 30, 2020

 
         

Electronics

 $75,836  $55,271 
         

Engraving Services

  32,917   34,320 

Engraving Products

  2,253   2,081 

Total Engraving

  35,170   36,401 
         

Scientific

  21,529   16,663 
         

Engineering Technologies

  17,573   17,633 
         

Hydraulics Cylinders and Systems

  10,653   12,331 

Merchandising & Display

  6,688   7,198 

Pumps

  8,161   5,789 

Total Specialty Solutions

  25,502   25,318 
         

Total revenue by product line

 $175,610  $151,286 

 

The following table presents revenue from continuing operations disaggregated by geography based on company’s locations (in thousands):

 

  

Three Months Ended

  

Three Months Ended

 

Net sales

 

September 30, 2021

  

September 30, 2020

 

United States

 $98,984  $92,114 

Asia Pacific

  37,256   26,864 

EMEA (1)

  36,001   28,818 

Other Americas

  3,369   3,490 

Total

 $175,610  $151,286 

 

(1) EMEA consists primarily of Europe, Middle East and S. Africa. 

 

10

 

The following table presents revenue from continuing operations disaggregated by timing of recognition (in thousands) for the three months ended:

 

  

Three Months Ended

 

Timing of Revenue Recognition

 

September 30, 2021

  

September 30, 2020

 

Products and services transferred at a point in time

 $164,423  $143,471 

Products transferred over time

  11,187   7,815 

Net sales

 $175,610  $151,286 

 

Contract Balances

 

Contract assets represent sales recognized in excess of billings related to work completed but not yet shipped for which revenue is recognized over time. Contract assets are recorded as prepaid and other current assets. Contract liabilities are customer deposits for which revenue has not been recognized. Current contract liabilities are recorded as accrued expenses.

 

The timing of revenue recognition, invoicing and cash collections results in billed receivables, contract assets and contract liabilities on the consolidated balance sheets. When consideration is received from a customer prior to transferring goods or services to the customer under the terms of a contract, a contract liability is recorded. Contract liabilities are recognized as revenue after control of the goods and services are transferred to the customer and all revenue recognition criteria have been met.

 

The following table provides information about contract assets and liability balances (in thousands):

 

  

Balance at Beginning of Period

  

Additions

  

Deductions

  

Balance at
End of Period

 

Three months ended September 30, 2021

                

Contract assets:

                

Prepaid expenses and other current assets

 $15,013  $9,087  $5,965  $18,135 

Contract liabilities:

                

Customer deposits

  471   2,955   3,174   252 
                 
  

Balance at Beginning of Period

  

Additions

  

Deductions

  

Balance at
End of Period

 

Three months ended September 30, 2020

                

Contract assets:

                

Prepaid expenses and other current assets

 $9,140  $6,054  $7,187  $8,007 

Contract liabilities:

                

Customer deposits

  2,298   1,873   2,753   1,418 

 

We recognized the following revenue which was included in the contract liability beginning balances (in thousands):

 

Revenue recognized in the period from:

 

September 30, 2021

 

Amounts included in the contract liability balance at the beginning of the period

 $471 
     
     

Revenue recognized in the period from:

 

September 30, 2020

 

Amounts included in the contract liability balance at the beginning of the period

 $2,298 

 

11

 

4)      Fair Value Measurements

 

The financial instruments shown below are presented at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Where available, fair value is based on observable market prices or parameters or derived from such prices or parameters. Where observable prices or inputs are not available, valuation models may be applied.

 

Assets and liabilities recorded at fair value in the consolidated balance sheet are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Hierarchical levels directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities and the methodologies used in valuation are as follows:

 

Level 1 – Quoted prices (unadjusted) in active markets for identical assets and liabilities. The Company’s deferred compensation plan assets consist of shares in various mutual funds (investments are participant-directed) which invest in a broad portfolio of debt and equity securities. These assets are valued based on publicly quoted market prices for the funds’ shares as of the balance sheet dates.

 

Level 2 – Inputs, other than quoted prices in an active market, that are observable either directly or indirectly through correlation with market data. For foreign exchange forward contracts and interest rate swaps, the Company values the instruments based on the market price of instruments with similar terms, which are based on spot and forward rates as of the balance sheet dates. The Company has considered the creditworthiness of counterparties in valuing all assets and liabilities.

 

Level 3 – Unobservable inputs based upon the Company’s best estimate of what market participants would use in pricing the asset or liability.

 

There were no transfers of assets or liabilities between any levels of the fair value measurement hierarchy at September 30, 2021 and June 30, 2021. The Company’s policy is to recognize transfers between levels as of the date they occur.

 

Cash and cash equivalents, accounts receivable, accounts payable, and debt are carried at cost, which approximates fair value.

 

The fair values of financial instruments at September 30, 2021 and June 30, 2021 were (in thousands):

 

  

September 30, 2021

 
  

Total

  

Level 1

  

Level 2

  

Level 3

 

Assets

                

Marketable securities - deferred compensation plan

 $3,175  $3,175  $-  $- 

Foreign exchange contracts

  71   -   71   - 
                 

Liabilities

                

Foreign exchange contracts

 $-  $-   -  $- 

Interest rate swaps

  2,555   -   2,555   - 

Contingent acquisition payments (a)

  2,167   -   -   2,167 

 

 

  

June 30, 2021

 
  

Total

  

Level 1

  

Level 2

  

Level 3

 

Assets

                

Marketable securities - deferred compensation plan

 $2,988  $2,988  $-  $- 

Foreign exchange contracts

  255   -   255   - 
                 

Liabilities

                

Foreign exchange contracts

 $1,222  $-  $1,222  $- 

Interest rate swaps

  3,096   -   3,096   - 

Contingent acquisition payments (a)

  3,333   -   -   3,333 

 

(a) The fair value of contingent consideration arrangements is determined based on the Company's evaluation as to the probability and amount of any contingent consideration that has been earned to date.

 

The financial liabilities based upon Level 3 inputs include contingent consideration arrangements relating to the acquisitions of Renco Electronics or GS Engineering. The Company is contractually obligated to pay contingent consideration payments to the Sellers of these businesses based on the achievement of certain criteria.

 

12

 

The Company is contractually obligated to pay contingent consideration to the sellers of GS Engineering in the event that certain revenue and gross margin targets are achieved during the five years following acquisition. The targets set in the GS stock purchase agreement were not met for the first or second year, which concluded in the fourth quarter of fiscal years 2020 and 2021, respectively. As of September 30, 2021, the Company could be required to pay up to $12.8 million for contingent consideration arrangements if the revenue and gross margin targets are met in fiscal years 2022 through 2024.

 

The Company is also obligated to pay contingent consideration to the sellers of Renco Electronics in the event that certain earnings targets are achieved during the three years following acquisition. Contingent acquisition payments are scheduled to be paid in periods through fiscal year 2024. As of September 30, 2021, the Company could be required to pay up to an additional $2.2 million for contingent consideration arrangements if the earnings targets are met. During the first quarter of fiscal year 2022, the Company paid $1.2 million to the sellers as Renco exceeded the earnings targets during the first year of the measurement period.

 

The Company has determined the fair value of the liabilities for the contingent consideration based on a probability-weighted discounted cash flow analysis. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement within the fair value hierarchy. The fair value of the contingent consideration liability associated with future payments was based on several factors, the most significant of which are the financial performance of the acquired businesses and the risk-adjusted discount rate for the fair value measurement.

 

The Company will update its assumptions each reporting period based on new developments and record such amounts at fair value based on the revised assumptions until the agreements expire.

 

5)     Inventories

 

Inventories from continuing operations are comprised of the following (in thousands):

 

  

September 30, 2021

  

June 30, 2021

 

Raw materials

 $45,447  $47,000 

Work in process

  26,071   22,539 

Finished goods

  28,564   22,323 

Total

 $100,082  $91,862 

 

Distribution costs associated with the sale of inventory, which are recorded as a component of selling, general and administrative expenses in the accompanying unaudited condensed consolidated statements of operations were $3.7 million and $2.5 million for the three months ended   September 30, 2021 and 2020, respectively.

 

 

6)     Goodwill

 

Changes to goodwill by segment during the period were as follows (in thousands):

 

  

June 30, 2021

  

Acquisitions

  

Impairments

  

Translation Adjustment

  

September 30, 2021

 

Electronics

 $144,832  $-  $-  $(657) $144,175 

Engraving

  77,378   -   -   (239)  77,139 

Scientific

  15,454   -   -   -   15,454 

Engineering Technologies

  37,085   -   -   (250)  36,835 

Specialty Solutions

  3,305   -   -   -   3,305 

Total

 $278,054  $-  $-  $(1,146) $276,908 

 

 

 

7)     Warranty Reserves

 

The expected cost associated with warranty obligations on our products is recorded as a component of cost of sales when the revenue is recognized. The Company’s estimate of warranty cost is based on contract terms and historical warranty loss experience that is periodically adjusted for recent actual experience. Since warranty estimates are forecasts based on the best available information, claims costs may differ from amounts provided. Adjustments to initial obligations for warranties are made as changes in the obligations become reasonably estimable.

 

13

 

The changes in warranty reserves from continuing operations, which are recorded as a component of accrued liabilities were as follows (in thousands):

 

  

September 30, 2021

  

June 30, 2021

 

Balance at beginning of year

 $2,086  $1,781 

Acquisitions and other charges

  (21)  68 

Warranty expense

  376   2,007 

Warranty claims

  (311)  (1,770)

Balance at end of period

 $2,130  $2,086 

 

 

 

8)     Debt

 

Long-term debt is comprised of the following (in thousands):

 

  

September 30, 2021

  

June 30, 2021

 

Bank credit agreements

 $200,000  $200,000 

Total funded debt

  200,000   200,000 

Issuance cost

  (425)  (510)

Total long-term debt

 $199,575  $199,490 

 

Bank Credit Agreements

 

During the second quarter of fiscal year 2019, the Company entered into a five-year Amended and Restated Credit Agreement (“Credit Facility”, or “facility”). The facility has a borrowing limit of $500 million, which can be increased by an amount of up to $250 million, in accordance with specified conditions contained in the agreement. The facility also includes a $10 million sublimit for swing line loans and a $35 million sublimit for letters of credit.

 

At September 30, 2021, the Company had standby letters of credit outstanding, primarily for insurance purposes, of $6.1 million and had the ability to borrow $267.1 million under the facility. Funds borrowed under the facility  may be used for the repayment of debt, working capital, capital expenditures, acquisitions (so long as certain conditions, including a specified funded debt to EBITDA leverage ratio is maintained), and other general corporate purposes.  The facility contains customary representations, warranties and restrictive covenants, as well as specific financial covenants which the Company was compliant with as of  September 30, 2021.  At September 30, 2021, the carrying value of the current borrowings approximate fair value.

 

9)

Accrued Liabilities

 

Accrued expenses from continuing operations consist of the following (in thousands):

 

  

September 30, 2021

  

June 30, 2021

 

Payroll and employee benefits

 $21,573  $32,550 

Workers' compensation

  2,257   2,118 

Warranty reserves

  2,130   2,086 

Fair value of derivatives

  2,555   4,318 

Operating lease current liability

  7,762   7,933 

Other

  14,290   12,712 

Total

 $50,567  $61,717 
 

 

10)      Derivative Financial Instruments

 

The Company is exposed to market risks from changes in interest rates, commodity prices and changes in foreign currency rates. The Company selectively uses derivative financial instruments in order to manage certain of these risks. Information about the Company’s derivative financial instruments is as follows:

 

14

 

Interest Rate Swaps

 

From time to time as dictated by market opportunities, the Company enters into interest rate swap agreements designed to manage exposure to interest rates on the Company’s variable rate indebtedness. The Company recognizes all derivatives on its balance sheet at fair value. The Company has designated its interest rate swap agreements, including those that may be forward-dated, as cash flow hedges, and changes in the fair value of the swaps are recognized in other comprehensive income until the hedged items are recognized in earnings. Hedge ineffectiveness, if any, associated with the swaps will be reported by the Company in interest expense.

 

The Company’s effective swap agreements convert the base borrowing rate on $200 million of debt due under our revolving credit agreement from a variable rate equal to 1 month LIBOR to a weighted average fixed rate of 1.27% at September 30, 2021. The fair value of the swaps, recognized in accrued expenses and in other comprehensive income, is as follows (in thousands, except percentages):

 

Effective Date

 

Notional Amount

  

Fixed Interest Rate

 

Maturity

 

September 30, 2021

  

June 30, 2021

 

May 24, 2017

 

25,000

  

1.88%

 

April 24, 2022

 $(263) $(374)

August 6, 2018

 

25,000

  

2.83%

 

August 6, 2023

  (1,242)  (1,401)

March 23, 2020

 

100,000

  

0.91%

 

March 23, 2025

  (727)  (907)

April 24, 2020

 

25,000

  

0.88%

 

April 24, 2025

  (146)  (192)

May 24, 2020

 

25,000

  

0.91%

 

March 24, 2025

  (177)  (222)
       $(2,555) $(3,096)

 

The Company reported no losses for the three months ended September 30, 2021, as a result of hedge ineffectiveness. Future changes in these swap arrangements, including termination of the agreements, may result in a reclassification of any gain or loss reported in accumulated other comprehensive income (loss) into earnings as an adjustment to interest expense. Accumulated other comprehensive income (loss) related to these instruments is being amortized into interest expense concurrent with the hedged exposure.

 

Foreign Exchange Contracts

 

Forward foreign currency exchange contracts are used to limit the impact of currency fluctuations on certain anticipated foreign cash flows, such as collections from customers and loan payments between subsidiaries. The Company enters into such contracts for hedging purposes only. The Company has designated certain of these currency contracts as hedges, and changes in the fair value of these contracts are recognized in other comprehensive income until the hedged items are recognized in earnings. Hedge ineffectiveness, if any, associated with these contracts will be reported in net income. At September 30, 2021 and June 30, 2021, the Company had outstanding forward contracts related to hedges of intercompany loans with net unrealized gains of less than $0.1 million and losses of $1.0 million, respectively, which approximate the unrealized gains and losses on the related loans. The contracts have maturity dates ranging from fiscal year 2022 to 2024, which correspond to the related intercompany loans.

 

The notional amounts of the Company’s forward contracts, by currency, are as follows (in thousands):

 

Currency

 

September 30, 2021

  

June 30, 2021

 

USD

  -   987 

EUR

  5,750   5,750 

SGD

  21,784   21,836 

CAD

  20,600   20,600 

 

15

 

The table below presents the fair value of derivative financial instruments as well as their classification on the balance sheet (in thousands):

 

Asset Derivatives

 
 

September 30, 2021

 

June 30, 2021

 

Derivative designated

Balance

    

Balance

    

as hedging instruments

Sheet

    

Sheet

    
 

Line Item

 

Fair Value

 

Line Item

 

Fair Value

 

Foreign exchange contracts

Other assets

 $71 

Other assets

 $255 
   $71   $255 

 

 

Liability Derivatives

 
 

September 30, 2021

 

June 30, 2021

 

Derivative designated

Balance

    

Balance

    

as hedging instruments

Sheet

    

Sheet

    
 

Line Item

 

Fair Value

 

Line Item

 

Fair Value

 

Interest rate swaps

Accrued liabilities

 $2,555 

Accrued liabilities

 $3,096 

Foreign exchange contracts

Accrued liabilities

  - 

Accrued liabilities

  1,222 
   $2,555   $4,318 

 

The table below presents the amount of gain (loss) recognized in comprehensive income on our derivative financial instruments (effective portion) designated as hedging instruments and their classification within comprehensive income for the periods ended (in thousands):

 

  

Three Months Ended

 
  

September 30,

 
  

2021

  

2020

 

Interest rate swaps

 $(61) $(457)

Foreign exchange contracts

  204   (114)
  $143  $(571)

 

The table below presents the amount reclassified from accumulated other comprehensive income (loss) to net income for the periods ended (in thousands):

 

Details about Accumulated

        

Affected line item

Other Comprehensive

 

Three Months Ended

 

in the Unaudited

Income (Loss) Components

 

September 30,

 

Condensed Statements

  

2021

  

2020

 

of Operations

Interest rate swaps

 $602  $556 

Interest expense

Foreign exchange contracts

  482   31 

Other non-operating (income) expense, net

  $1,084  $587  

 

 

11)     Retirement Benefits

 

The Company has defined benefit pension plans covering certain current and former employees both inside and outside of the U.S. The Company’s pension plan for U.S. employees is frozen for substantially all participants and has been replaced with a defined contribution benefit plan.

 

16

 

Net periodic benefit cost for the Company’s U.S. and Foreign pension benefit plans for the periods ended consisted of the following components (in thousands):

 

  

U.S. Plans

  

Non-U.S. Plans

 
  

Three Months Ended

  

Three Months Ended

 
  

September 30,

  

September 30,

 
  

2021

  

2020

  

2021

  

2020

 

Service cost

 $1  $1  $63  $54 

Interest cost

  1,830   1,860   190   176 

Expected return on plan assets

  (3,260)  (3,253)  (211)  (153)

Recognized net actuarial loss

  1,384   1,483   84   184 

Amortization of prior service cost

  -   -   (1)  (1)

Net periodic benefit cost

 $(45) $91  $125  $260 

 

The following table sets forth the amounts recognized for the Company's defined benefit pension plans (in thousands):

 

Amounts recognized in the consolidated balance sheets consist of:

 

September 30, 2021

  

June 30, 2021

 

Prepaid benefit cost

 $5,563  $5,661 

Current liabilities

  (538)  (517)

Non-current liabilities

  (45,781)  (47,425)

Net amount recognized

 $(40,756) $(42,281)

 

The contributions made to defined benefit plans are presented below along with remaining contributions to be made for fiscal year 2022 (in thousands):

 

  

Three Months Ended

  

Remaining

 
  

September 30,

  

Contributions

 

Contributions to defined benefit plans

 

2021

  

2020

  

FY 2022

 

United States, funded plan

 $-  $-  $1,002 

United States, unfunded plan

  52   52   159 

United Kingdom

  -   -   - 

Germany, unfunded plan

  -   -   287 

Ireland

  -   -   67 
  $52  $52  $1,515 

 

 

12)     Income Taxes

 

The Company's effective tax rate from continuing operations for the first quarter of fiscal year 2022 was 25.0% compared with 20.7% for the prior year quarter. The tax rate was impacted in the current period by the following items: (i) a discrete tax benefit related to equity compensation, (ii) the jurisdictional mix of earnings, (iii) foreign withholding taxes, and (iv) increased capacity to utilize foreign tax credits.

 

 

 

 

13)     Earnings Per Share

 

The following table sets forth a reconciliation of the number of shares (in thousands) used in the computation of basic and diluted earnings per share:

 

  

Three Months Ended

 
  

September 30,

 
  

2021

  

2020

 

Basic - Average shares outstanding

  12,023   12,228 

Dilutive effect of unvested, restricted stock awards

  126   53 

Diluted - Average shares outstanding

  12,149   12,281 

 

17

 

Earnings available to common stockholders are the same for computing both basic and diluted earnings per share. There were no outstanding instruments that had an anti-dilutive effect at September 30, 2021. There were 11,352 outstanding instruments that had an anti-dilutive effect at  September 30, 2020.

 

Performance stock units of 131,888 and 130,461 for the three months ended September 30, 2021 and 2020, respectively, are excluded from the diluted earnings per share calculation as the performance criteria have not been met.

 

14)     Accumulated Other Comprehensive Income (Loss)

 

The components of the Company’s accumulated other comprehensive income (loss) are as follows (in thousands):

 

  

September 30, 2021

  

June 30, 2021

 

Foreign currency translation adjustment

 $(23,660) $(21,244)

Unrealized pension losses, net of tax

  (91,175)  (92,372)

Unrealized losses on derivative instruments, net of tax

  (1,431)  (2,524)

Total

 $(116,266) $(116,140)

 

 

 

15)     Contingencies

 

From time to time, the Company is subject to various claims and legal proceedings, including claims related to environmental remediation, either asserted or unasserted, that arise in the ordinary course of business. While the outcome of these proceedings and claims cannot be predicted with certainty, the Company’s management does not believe that the outcome of any of the currently existing legal matters will have a material impact on the Company’s consolidated financial position, results of operations or cash flow. The Company accrues for losses related to a claim or litigation when the Company’s management considers a potential loss probable and can reasonably estimate such potential loss.

 

Litigation

 

In the second quarter of fiscal year 2019, a lawsuit was filed against Standex Electronics, Inc., a wholly owned subsidiary of the Company (“Electronics”), by Miniature Precision Components, Inc., a customer (“MPC”), seeking damages in connection with allegedly faulty sensors designed and manufactured by Electronics.  The subject sensors were incorporated by MPC into a subassembly sold by MPC to its customer, an automotive manufacturer. MPC alleges that the sensors incorrectly activated a diagnostic code in vehicles for which MPC’s customer issued a service bulletin, resulting in significant warranty costs for MPC. In the litigation, which is pending in the U.S. District Court for the Eastern District of Wisconsin, MPC seeks indemnification from Electronics for its costs. Electronics has numerous defenses to MPC’s claims and, based upon discovery completed to date, the Company believes that liability to Electronics, while possible, is not probable, and the range of any potential liability would be between $0 and $4.0 million. There have been no accrued liabilities recorded related to this litigation. 

 

 

16)     Industry Segment Information

 

The Company has five reportable segments organized around the types of products sold:

 

 

Electronics – manufactures and sells electronic components for applications throughout the end user market spectrum;

 

Engraving – provides mold texturizing, slush molding tools, project management and design services, roll engraving, hygiene product tooling, low observation vents for stealth aircraft, and process machinery for a number of industries; 

 

Scientific – sells specialty temperature-controlled equipment for the medical, scientific, pharmaceutical, biotech and industrial markets; 

 

Engineering Technologies – provides net and near net formed single-source customized solutions in the manufacture of engineered components for the aviation, aerospace, defense, energy, industrial, medical, marine, oil and gas, and manned and unmanned space markets; 

 

Specialty Solutions – an aggregation of three operating segments that manufacture and sell refrigerated, heated and dry merchandizing display cases, custom fluid pump solutions, and single and double acting telescopic and piston rod hydraulic cylinders. 

 

 

18

 

Net sales and income (loss) from continuing operations by segment were as follows (in thousands):

 

  

Three Months Ended September 30,

 
  

Net Sales

  

Income from Operations

 
  

2021

  

2020

  

2021

  

2020

 

Industry segment:

                

Electronics

 $75,836  $55,271  $18,273  $8,535 

Engraving

  35,170   36,401   4,874   5,873 

Scientific

  21,529   16,663   4,508   4,076 

Engineering Technologies

  17,573   17,633   899   469 

Specialty Solutions

  25,502   25,318   2,815   3,906 

Corporate

  -   -   (7,884)  (6,992)

Restructuring costs

  -   -   (440)  (1,488)

Acquisition related costs

  -   -   (217)  (25)

Sub-total

 $175,610  $151,286  $22,828  $14,354 

Interest expense

          1,720   1,484 

Other non-operating (income) expense

          23   (173)

Income from continuing operations before income taxes

         $21,085  $13,043 

 

 

 

Net sales include only transactions with unaffiliated customers and include no intersegment sales. Income (loss) from operations by segment excludes interest expense and other non-operating (income) expense.

 

 

17)      Restructuring

 

The Company has undertaken a number of initiatives that have resulted in severance, restructuring, and related charges.

 

2022 Restructuring Initiatives

 

The Company continues to focus its efforts to reduce cost and improve productivity across its businesses, particularly through headcount reductions, facility closures, and consolidations. Restructuring expenses primarily related to headcount reductions and other cost saving initiatives. The Company expects the 2022 restructuring activities to be completed by 2023. 

 

Prior Year Restructuring Initiatives 

 

Restructuring expenses primarily related to headcount reductions and facility rationalization within our Specialty Solutions segment. The Company also incurred restructuring expenses related to third party assistance with analysis and implementation of these activities. The Company expects the prior year restructuring activities to be completed by 2022.

 

19

 

A summary of charges by initiative is as follows (in thousands):

 

  

Three Months Ended

 
  

September 30, 2021

 

Fiscal Year 2022

 

Involuntary Employee Severance and Benefit Costs

  

Other

  

Total

 

Current year initiatives

 $375  $65  $440 

Prior year initiatives

  -   -   - 
  $375  $65  $440 

 

  

Three Months Ended

 
  

September 30, 2020

 

Fiscal Year 2021

 

Involuntary Employee Severance and Benefit Costs

  

Other

  

Total

 

Current year initiatives

 $242  $161  $403 

Prior year initiatives

  812   273   1,085 
  $1,054  $434  $1,488 

 

Activity in the reserve related to the initiatives is as follows (in thousands):

 

Current Year Initiatives

 

Involuntary Employee Severance and Benefit Costs

  

Other

  

Total

 

Restructuring liabilities at June 30, 2021

 $-  $-  $- 

Additions and adjustments

  375   65   440 

Payments

  (375)  (65)  (440)

Restructuring liabilities at September 30, 2021

 $-  $-  $- 

 

Prior Year Initiatives

 

Involuntary Employee Severance and Benefit Costs

  

Other

  

Total

 

Restructuring liabilities at June 30, 2021

 $39  $10  $49 

Additions and adjustments

  -   -   - 

Payments

  (39)  (10)  (49)

Restructuring liabilities at September 30, 2021

 $-  $-  $- 

 

             

Prior Year Initiatives

 

Involuntary Employee Severance and Benefit Costs

  

Other

  

Total

 

Restructuring liabilities at June 30, 2020

 $520  $18  $538 

Additions and adjustments

  1,054   434   1,488 

Payments

  (1,483)  (419)  (1,902)

Restructuring liabilities at September 30, 2020

 $91  $33  $124 

 

20

 

The Company’s total restructuring expenses by segment are as follows (in thousands):

 

  

Three Months Ended

 
  

September 30, 2021

 
  

Involuntary Employee Severance and Benefit Costs

  

Other

  

Total

 

Electronics

 $-  $-  $- 

Engraving

  284   65   349 

Engineering Technologies

  91   -   91 

Specialty Solutions

  -   -   - 

Corporate

  -   -   - 
  $375  $65  $440 

 

 

  

Three Months Ended

 
  

September 30, 2020

 
  

Involuntary Employee Severance and Benefit Costs

  

Other

  

Total

 

Electronics

 $169  $5  $174 

Engraving

  91   147   238 

Engineering Technologies

  35   -   35 

Specialty Solutions

  673   282   955 

Corporate

  86   -   86 
  $1,054  $434  $1,488 

 

Restructuring expense is expected to be approximately $1.6 million for the remainder of fiscal year 2022.

 

21

 
 

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

 

Statements contained in this Quarterly Report that are not based on historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of forward-looking terminology such as should, could, may, will, expect, believe, estimate, anticipate, intend, continue, or similar terms or variations of those terms or the negative of those terms. There are many factors that affect the Companys business and the results of its operations and that may cause the actual results of operations in future periods to differ materially from those currently expected or anticipated. These factors include, but are not limited to: the impact of pandemics such as the current coronavirus on employees, our supply chain, and the demand for our products and services around the world; materially adverse or unanticipated legal judgments, fines, penalties or settlements; conditions in the financial and banking markets, including fluctuations in exchange rates and the inability to repatriate foreign cash; domestic and international economic conditions, including the impact, length and degree of economic downturns on the customers and markets we serve and more specifically conditions in the automotive, construction, aerospace, defense, transportation, food service equipment, consumer appliance, energy, oil and gas and general industrial markets; lower-cost competition; the relative mix of products which impact margins and operating efficiencies in certain of our businesses; the impact of higher raw material and component costs, particularly steel, certain materials used in electronics parts, petroleum based products, and refrigeration components; the impact of higher transportation and logistics costs, especially with respect to transportation of goods from Asia; the impact of inflation on the costs of providing our products and services; an inability to realize the expected cost savings from restructuring activities including effective completion of plant consolidations, cost reduction efforts including procurement savings and productivity enhancements, capital management improvements, strategic capital expenditures, and the implementation of lean enterprise manufacturing techniques; the potential for losses associated with the exit from or divestiture of businesses that are no longer strategic or no longer meet our growth and return expectations; the inability to achieve the savings expected from global sourcing of raw materials and diversification efforts in emerging markets; the impact on cost structure and on economic conditions as a result of actual and threatened increases in trade tariffs; the inability to attain expected benefits from acquisitions and the inability to effectively consummate and integrate such acquisitions and achieve synergies envisioned by the Company; market acceptance of our products; our ability to design, introduce and sell new products and related product components; the ability to redesign certain of our products to continue meeting evolving regulatory requirements; the impact of delays initiated by our customers; our ability to increase manufacturing production to meet demand including as a result of labor shortages; and potential changes to future pension funding requirements. In addition, any forward-looking statements represent management's estimates only as of the day made and should not be relied upon as representing management's estimates as of any subsequent date. While the Company may elect to update forward-looking statements at some point in the future, the Company and management specifically disclaim any obligation to do so, even if management's estimates change.

 

Overview

 

We are a diversified industrial manufacturer with leading positions in a variety of products and services that are used in diverse commercial and industrial markets. We have seven operating segments aggregated into five reportable segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. Three operating segments are aggregated into Specialty Solutions. Our segments differentiate themselves by collaborating with our customers in order to develop and deliver custom solutions or engineered components that solve problems for our customers or otherwise meet their needs (a business model we refer to as “Customer Intimacy”). Overall management, strategic development and financial control are led by the executive staff at our corporate headquarters located in Salem, New Hampshire. 

 

Our long-term strategy is to enhance shareholder value by building larger, more profitable focused industrial platforms through our Standex Value Creation System that assists management in meeting specific corporate and business unit financial and strategic performance goals in order to create, improve, and enhance shareholder value. In so doing, we expect to focus our financial assets and managerial resources on our higher growth and operating margin businesses while considering divestiture of those businesses that we feel are not strategic or do not meet our growth and return expectations. 

 

22

 

The Standex Value Creation System is a methodology which provides standard work and consistent tools used throughout the Company in order to achieve our organization’s goals. The Standex Value Creation System employs four components: Balanced Performance Plan, Growth Disciplines, Operational Excellence, and Talent Management. The Balanced Performance Plan process aligns annual goals throughout the Company and provides a standard reporting, management and review process.  It is focused on setting, tracking and reviewing annual and quarterly targets that support our short and long-term goals.  The Growth Disciplines use a standard playbook of tools and processes including market maps, market tests and growth laneways to identify, explore and execute on opportunities that expand the business organically and through acquisitions.  Operational Excellence also employs a standard playbook of tools and processes, based on Lean, to improve operating execution (effectiveness), eliminate waste (efficiency) and thereby improve profitability, cash flow and customer satisfaction.  Finally, Talent Management is an organizational development process that provides recruitment, training, development, and succession planning for employees throughout our worldwide organization.  Through the use of our Standex Value Creation System, we have developed a balanced approach to value creation.  We intend to continue investing acquisition capital in high margin and growth businesses, and we will continue to support all of our businesses as they enhance value through deployment of the Standex Valuation Creation System.

 

It is our objective to grow larger and more profitable business units through both organic initiatives and acquisitions.  We seek to identify and implement organic growth initiatives such as new product development, geographic expansion, the introduction of products and technologies into new markets, key accounts and strategic sales channel partners, and the introduction of new technologies into existing markets. Also, we have a long-term objective to create sizable business platforms by adding strategically aligned or “bolt on” acquisitions to strengthen the individual businesses, create both sales and cost synergies with our core business platforms, and accelerate their growth and margin improvement.  We look to create both sales and cost synergies within our core business platforms, accelerate growth and improve margins.  We have a particular focus on identifying and investing in opportunities that complement our products and will increase the global presence and capabilities of our businesses.  From time to time, we have divested, and likely will continue to divest, businesses that we feel are not strategic or do not meet our growth and return expectations.

 

As part of our ongoing strategy:

 

 

In the third quarter of fiscal year 2021, we divested Enginetics Corporation (“Enginetics”) our jet engine components business reported within our Engineering Technologies segment, to Enjet Aero, LLC, a privately-held aerospace engine component manufacturing company. This divestiture allows us to focus on the higher growth and margin opportunities of our core spin forming solutions business that serves the space, commercial aviation and defense end markets. We received $11.7 million cash consideration and recorded a loss on the sale of $14.6 million in the Consolidated Financial Statements. 

 

 

In the first quarter of fiscal year 2021, we acquired Renco Electronics (“Renco”), a designer and manufacturer of customized standard magnetics components and products including transformers, inductors, chokes and coils for power and RF applications.  Renco’s end markets and customer base in areas such as consumer and industrial applications are highly complementary to our existing business with the potential to further expand key account relationships and capitalize on cross selling opportunities.  Renco operates one manufacturing facility in Florida and is supported by contract manufacturers in Asia.  Renco’s results are reported within our Electronics segment.

 

As a result of our portfolio moves, we have transformed Standex to a company with a more focused group of businesses selling customized solutions to high value end markets via a compelling customer value proposition.  The narrowing of the portfolio allows for greater management focus on driving operational disciplines and positions us well to continue benefitting from the economic rebound associated with the emergence from the end of the COVID-19 crisis and to use our cash flow from operations to invest selectively in our ongoing pipeline of organic and inorganic opportunities.

 

We develop “Customer Intimacy” by utilizing the Standex Growth Disciplines to partner with our customers in order to develop and deliver custom solutions or engineered components. By partnering with our customers during long-term product development cycles, we become an extension of their development teams. Through this Partner, Solve, Deliver® approach, we are able to secure our position as a preferred long-term solution provider for our products and components. This strategy results in increased sales and operating margins that enhance shareholder returns. 

 

Standex Operational Excellence drives continuous improvement in the efficiency of our businesses, both on the shop floor and in the office environment.  We recognize that our businesses are competing in a global economy that requires us to improve our competitive position.  We have deployed a number of management competencies to drive improvements in the cost structure of our business units including operational excellence through lean enterprise, the use of low-cost manufacturing facilities, the consolidation of manufacturing facilities to achieve economies of scale and leveraging of fixed infrastructure costs, alternate sourcing to achieve procurement cost reductions, and capital improvements to increase productivity.

 

The Company’s strong historical cash flow has been a cornerstone for funding our capital allocation strategy.  We use cash flow generated from operations to fund investments in capital assets to upgrade our facilities, improve productivity and lower costs, invest in the strategic growth programs described above, including organic growth and acquisitions, and to return cash to our shareholders through payment of dividends and stock buybacks. 

 

23

 

Restructuring expenses reflect costs associated with our efforts of continuously improving operational efficiency and expanding globally in order to remain competitive in our end user markets. We incur costs for actions to size our businesses to a level appropriate for current economic conditions, improve our cost structure, enhance our competitive position and increase operating margins. Such expenses include costs for moving facilities to locations that allow for lower fixed and variable costs, external consultants who provide additional expertise starting up plants after relocation, downsizing operations because of changing economic conditions, and other costs resulting from asset redeployment decisions.  Shutdown costs include severance, benefits, stay bonuses, lease and contract terminations, asset write-downs, costs of moving fixed assets, and moving and relocation costs. Vacant facility costs include maintenance, utilities, property taxes and other costs.

 

Because of the diversity of the Company’s businesses, end user markets and geographic locations, management does not use specific external indices to predict the future performance of the Company, other than general information about broad macroeconomic trends.  Each of our individual business units serves niche markets and attempts to identify trends other than general business and economic conditions which are specific to its business and which could impact its performance. Those units report pertinent information to senior management, which uses it to the extent relevant to assess the future performance of the Company. A description of any such material trends is described below in the applicable segment analysis.

 

We monitor a number of key performance indicators (“KPIs”) including net sales, income from operations, backlog, effective income tax rate, gross profit margin, and operating cash flow. A discussion of these KPIs is included below. We may also supplement the discussion of these KPIs by identifying the impact of foreign exchange rates, acquisitions, and other significant items when they have a material impact on a specific KPI. 

 

We believe the discussion of these items provides enhanced information to investors by disclosing their impact on the overall trend which provides a clearer comparative view of the KPI, as applicable.  For discussion of the impact of foreign exchange rates on KPIs, we calculate the impact as the difference between the current period KPI calculated at the current period exchange rate as compared to the KPI calculated at the historical exchange rate for the prior period.  For discussion of the impact of acquisitions, we isolate the effect on the KPI amount that would have existed regardless of such acquisition.  Sales resulting from synergies between the acquisition and existing operations of the Company are considered organic growth for the purposes of our discussion.

 

Unless otherwise noted, references to years are to fiscal years.

 

Impact of COVID-19 Pandemic on the Company

 

Given the global nature of our business and the number of our facilities worldwide, we continue to be impacted globally by COVID-19 related issues. We have taken effective action around the world to protect our health and safety, continue to serve our customers, support our communities and manage our cash flows.  Our priority was and remains the health and safety of all of our employees. Each of our facilities is following safe practices as defined in their local jurisdictions as well as sharing experiences and innovative ways of overcoming challenges brought on by the crisis during updates with global site leaders.  We are rigorously following health protocols in our plants, including changing work cell configurations and revising shift schedules when appropriate, in order to do our best to maintain operations. Initially we experienced revenue losses in many of our businesses due to the impact that the pandemic had on our customers. Conversely, public and private sector responses to COVID-19 vaccine distribution, especially in the United States, have also resulted in increased sales of scientific refrigeration equipment to customers within our Scientific reporting segment. More recently we have been impacted by (i) supply chain shortages and increased costs associated with the well-documented global logistics issues and (ii) labor shortages, especially in North America.

 

Given the impact that the pandemic created on our backlog and incoming order rate, we took actions to identify and implement cost savings and restructuring actions within each of our operating segments as well as our corporate headquarters.  Actions identified include reducing outside discretionary spend, the natural elimination of travel and trade show expenses that were a result of COVID-19 related curtailments, implementation of rolling furloughs in several businesses where appropriate, and the elimination of certain salaried and hourly positions. 

 

We exited the first quarter of fiscal year 2022 with $130.7 million in cash and $199.6 million of borrowings under our revolving credit facility.  Our leverage ratio covenant, as defined in our revolving credit agreement, was 1.24 to 1 and allowed us the capacity to borrow an additional $267.1 million at September 30, 2021. We believe that we have sufficient liquidity around the world and access to financing to execute on our short and long-term strategic plans. 

 

Finally, we continue to monitor our ability to participate in any governmental assistance programs available to us in each of our global locations and participate in these programs as available and appropriate. 

 

24

 

Results from Continuing Operations

 

   

Three Months Ended

 
   

September 30,

 

(In thousands, except percentages)

 

2021

   

2020

 

Net sales

  $ 175,610     $ 151,286  

Gross profit margin

    37.7 %     36.2 %

Income from operations

    22,828       14,354  

 

   

Three Months Ended

 

(In thousands)

 

September 30, 2021

 

Net sales, prior year period

  $ 151,286  

Components of change in sales:

       

Organic sales change

    25,608  

Effect of business divestitures

    (3,037 )

Effect of exchange rates

    1,753  

Net sales, current period

  $ 175,610  

 

Net sales increased in the first quarter of fiscal year 2022 by $24.3 million or 16.1% when compared to the prior year quarter. Organic sales increased $25.6 million or 16.9%, primarily due to strong demand in our Electronics segment, while foreign currency had a $1.8 million or 1.2% positive impact on sales.  

 

Gross Profit Margin

 

Our gross margin for the first quarter of fiscal year 2022 was 37.7%, which increased from the prior year quarter’s gross margin of 36.2%. This increase is a result of organic sales increases and productivity initiatives, partially offset by raw material and ocean freight cost headwinds, a one-time project related charge at Engineering Technologies, along with production decreases due to a temporary work stoppage in our Specialty Solutions segment which was resolved during the quarter.

 

Selling, General, and Administrative Expenses

 

Selling, General, and Administrative (“SG&A”)  expenses for the first quarter of fiscal year 2022 were $42.8 million, or 24.3% of sales, compared to $38.9 million, or 25.7% of sales, during the prior year quarter.  SG&A expenses during the quarter were impacted by increased distribution expense of approximately $1.2 million associated with higher organic sales volume in the quarter, increases in research and development initiatives and general wage inflation.

 

Restructuring Charges

 

We incurred restructuring expenses of $0.4 million in the first quarter of fiscal year 2022, primarily related to productivity improvements and global headcount reductions within our Engraving segment.

 

We expect to incur restructuring costs of approximately $1.6 million throughout the remainder of fiscal year 2022 as we continue to focus our efforts to reduce cost and improve productivity across our businesses, particularly through headcount reductions and productivity initiatives.

 

Acquisition Related Expenses

 

We incurred acquisition related expenses of $0.2 million in the first quarter of fiscal year 2022. Acquisition related expenses typically consist of due diligence, integration, and valuation expenses incurred in connection with recent or pending acquisitions.

 

25

 

Income from Operations

 

Income from operations for the first quarter of fiscal year 2022 was $22.8 million, compared to $14.4 million during the prior year quarter.  The increase of $8.5 million, or 59.0%, is primarily due to organic sales growth, productivity and cost savings initiatives, offset by increases in material and labor costs, including a temporary work stoppage which was resolved during the quarter.

 

Interest Expense

 

Interest expense for the first quarter of fiscal year 2022 was $1.7 million, a 15.9% increase from interest expense of $1.5 million during the prior year quarter. Our effective interest rate in the first quarter of fiscal year 2022 was 2.59%.

 

Income Taxes

 

Our effective tax rate from continuing operations for the first quarter of fiscal year 2022 was 25.0% compared with 20.7% for the prior year quarter. The tax rate was impacted in the current period by the following items: (i) a discrete tax benefit related to equity compensation, (ii) the jurisdictional mix of earnings, (iii) foreign withholding taxes, and (iv) increased capacity to utilize foreign tax credits.

 

Backlog

 

Backlog includes all active or open orders for goods and services. Backlog also includes any future deliveries based on executed customer contracts, so long as such deliveries are based on agreed upon delivery schedules. Backlog orders are not necessarily an indicator of future sales levels because of variations in lead times and customer production demand pull systems, with the exception of Engineering Technologies. Customers may delay delivery of products or cancel orders prior to shipment, subject to possible cancellation penalties. Due to the nature of long-term agreements in the Engineering Technologies segment, the timing of orders and delivery dates can vary considerably resulting in significant backlog changes from one period to another. In general, the majority of net realizable backlog beyond one year comes from the Engineering Technologies segment.

 

 

   

As of September 30, 2021

   

As of September 30, 2020

 
   

Total Backlog

   

Backlog under 1 year

   

Total Backlog

   

Backlog under 1 year

 

Electronics

  $ 134,974     $ 131,111     $ 62,442     $ 60,840  

Engraving

    25,483       19,333       18,873       14,695  

Scientific

    7,446       7,446       6,018       6,018  

Engineering Technologies

    56,667       43,283       91,363       59,816  

Specialty Solutions

    40,205       35,256       13,995       10,501  

Total

  $ 264,775     $ 236,429     $ 192,691     $ 151,870  

 

 

Total backlog realizable under one year increased $84.6 million, or 55.7%, to $236.4 million at September 30, 2021 from $151.9 million at September 30, 2020. Electronics backlog increased 116% in all geographic markets in response to the beginning of the global recovery from the pandemic and new business opportunities. Backlog declines in the Engineering Technologies segment are primarily due to the divestiture of Enginetics and the weakening demand in the commercial aviation sector due to COVID-19 pandemic related slowdowns in that industry.

 

Changes in backlog under one year are as follows (in thousands):

   

As of

 

(In thousands)

 

September 30, 2021

 

Backlog under 1 year, prior year period

  $ 151,870  

Components of change in backlog:

       

Organic change

    98,221  

Effect of divestitures

    (13,662 )

Backlog under 1 year, current period

  $ 236,429  

 

26

Segment Analysis

 

Overall

 

Looking forward to the remainder of fiscal year 2022, we expect to be well positioned to build on fiscal year 2021 and the first quarter of fiscal year 2022 momentum, with anticipated year over year improvement in key financial metrics, supported by orders growth and productivity initiatives.

 

In general for fiscal year 2022, we continue to expect: 

 

 

continued end market strength in reed switch and relay products as well as growth in magnetics in our Electronics segment;

 

an increase in soft trim demand in our Engraving segment;

 

a decline in demand for COVID-19 related vaccine storage in our Scientific segment;

 

continued strength in the commercial aviation market and growth in the space market in our Engineering Technologies segment; and

 

recovery in the food service market in our Specialty Solutions segment.

 

 

Electronics Group

 

   

Three Months Ended

         
   

September 30,

   

%

 

(In thousands, except percentages)

 

2021

   

2020

   

Change

 

Net sales

  $ 75,836     $ 55,271       37.2 %

Income from operations

    18,273       8,535       114.1 %

Operating income margin

    24.1 %     15.4 %        

 

Net sales in the first quarter of fiscal year 2022 increased $20.6 million, or 37.2%, when compared to the prior year quarter.  Organic sales increased by $19.9 million or 36.1%, reflecting a broad-based geographical recovery with a strengthening in demand for all product groups including relays in renewable energy and electric vehicle applications as well as reed switch demand in transportation end markets. The foreign currency impact increased sales by $0.6 million, or 1.1%. 

 

Income from operations in the first quarter of fiscal year 2022 increased by $9.7 million, or 114.1%, when compared to the prior year quarter. The operating income increase was the result of organic sales growth, various price actions and cost saving initiatives, offset by material cost increases.

 

Sequentially during the second quarter of fiscal year 2022, we expect a slight decline in revenue and operating margin mostly due to fewer production days and product mix.

 

Engraving Group

 

   

Three Months Ended

         
   

September 30,

   

%

 

(In thousands, except percentages)

 

2021

   

2020

   

Change

 

Net sales

  $ 35,170     $ 36,401       (3.4 %)

Income from operations

    4,874       5,873       (17.0 %)

Operating income margin

    13.9 %     16.1 %        

 

Net sales in the first quarter of fiscal year 2022 decreased by $1.2 million, or 3.4%, when compared to the prior year quarter. Organic sales decreased by $2.3 million, or 6.3%, as a result of timing of projects and weaknesses in the core hard trim markets.  Organic declines were offset by foreign exchange impacts of $1.0 million, or 2.7%. 

 

Income from operations in the first quarter of fiscal year 2022 decreased by $1.0 million, when compared to the prior year quarter.  Operating income declined during the quarter due to the impact of less favorable project mix, partially offset by productivity initiatives. 

 

Sequentially during the second quarter of fiscal year 2022, we expect a slight revenue and operating margin increase reflecting favorable regional mix, project timing, demand for soft trim tooling and productivity initiatives.

 

27

 

Scientific

 

   

Three Months Ended

         
   

September 30,

   

%

 

(In thousands, except percentages)

 

2021

   

2020

   

Change

 

Net sales

  $ 21,529     $ 16,663       29.2 %

Income from operations

    4,508       4,076       10.6 %

Operating income margin

    20.9 %     24.5 %        

 

Net sales in the first quarter of fiscal year 2022 increased by $4.9 million, or 29.2%, compared to the prior year quarter. The net sales increase reflects overall growth in end markets, including pharmaceutical channels and clinical settings in response to continued demand for cold storage surrounding COVID-19 vaccine distribution, and in academic laboratories due to the post pandemic recovery.

 

Income from operations in the first quarter of fiscal year 2022 increased $0.4 million, or 10.6%, when compared to the prior year quarter reflecting revenue growth partially offset by higher freight costs and investments in new product development.

 

Sequentially during the second quarter of fiscal year 2022, we expect similar revenue and operating margin due to continued strong demand in our end markets and pricing actions, partially offset by increased freight costs.

 

 

Engineering Technologies Group

 

   

Three Months Ended

         
   

September 30,

   

%

 

(In thousands, except percentages)

 

2021

   

2020

   

Change

 

Net sales

  $ 17,573     $ 17,633       (0.3 %)

Income from operations

    899       469       91.7 %

Operating income margin

    5.1 %     2.7 %        

 

Net sales in the first quarter of fiscal year 2022  decreased by $0.1 million, or 0.3%, compared to the prior year quarter. Sales in the prior year quarter included revenue of $3.0 million related to our divested Enginetics business.  Excluding the impact of the divestiture, sales increased $3.0 million due to the sharp increase in general economic activity over the last twelve months, particularly in the commercial aviation industry, along with an increase in sales into the space end market, particularly related to commercial space travel.  

 

Income from operations increased in the first quarter of fiscal year 2022 compared to the prior year period primarily due to productivity and cost savings measures implemented during the pandemic and maintained as economic activity resumed along with the absences of losses associated with the Enginetics business, offset by a $1.1 million one-time project-related charge during the quarter.

 

Sequentially during the second quarter of fiscal year 2022, we expect revenue to be similar due to strength in the commercial aviation and defense end markets, partially offset by project timing in the space end market. Operating margin is expected to increase significantly due to project mix complemented by ongoing productivity initiatives and the absence of the one-time project-related charge in the first quarter of fiscal year 2022.

 

28

 

Specialty

 

   

Three Months Ended

         
   

September 30,

   

%

 

(In thousands, except percentages)

 

2021

   

2020

   

Change

 

Net sales

  $ 25,502     $ 25,318       0.7 %

Income from operations

    2,815       3,906       (27.9 %)

Operating income margin

    11.0 %     15.4 %        

 

Net sales in the first quarter of fiscal year 2022 increased $0.2 million or 0.7% when compared to the prior year quarter. Organic sales increased $0.2 million, or 0.8%. Increased sales volume is primarily due to a continued recovery in the Pumps business, partially offset by the impact of a temporary work stoppage. The work stoppage was resolved during the first quarter.

 

Income from operations decreased $1.1 million or 27.9% in the first quarter of fiscal year 2022 when compared to the prior year quarter primarily as a result of higher costs of labor, including a temporary work stoppage and material price increases. 

 

Sequentially during the second quarter of fiscal year 2022, we expect a moderate revenue and operating margin increase due to a return to previous production levels after the work stoppage and strong demand across our end markets.

 

Corporate and Other

 

   

Three Months Ended

         
   

September 30,

   

%

 

(In thousands, except percentages)

 

2021

   

2020

   

Change

 

Income (loss) from operations:

                       

Corporate

  $ (7,884 )   $ (6,992 )     12.8 %

Restructuring

    (440 )     (1,488 )     (70 %)

Acquisition related costs

    (217 )     (25 )     768.0 %

 

Corporate expenses in the first quarter of fiscal year 2022 increased by 12.8% when compared to the prior year quarter. The increase primarily reflects general wage inflation and increased research and development costs.

 

The restructuring and acquisition related costs have been discussed above in the Company Overview.

 

Discontinued Operations

 

In pursuing our business strategy, the Company may divest certain businesses.  Future divestitures may be classified as discontinued operations based on their strategic significance to the Company. Net loss from Discontinued Operations were $0.0 million and $0.6 million as of September 30, 2021 and September 30, 2020 respectively.

 

 

Liquidity and Capital Resources

 

At September 30, 2021, our total cash balance was $130.7 million, of which $102.2 million was held by foreign subsidiaries.  During the first quarter of fiscal year 2022, we did not repatriate any cash to the United States from our foreign subsidiaries. We expect to repatriate between $15.0 million and $20.0 million during the second quarter of fiscal year 2022 and an additional $15.0 million during the second half of fiscal year 2022, however, the amount and timing of cash repatriation during the fiscal year will be dependent upon each business unit’s operational needs including requirements to fund working capital, capital expenditure, and jurisdictional tax payments. The repatriation of cash balances from certain of our subsidiaries could have adverse tax consequences or be subject to capital controls; however, those balances are generally available without legal restrictions to fund ordinary business operations.

 

Net cash provided by continuing operating activities for the three months ended September 30, 2021, was $13.1 million compared to net cash provided by continuing operating activities of $9.2 million in the prior year.  We generated $9.8 million from income statement activities and used $12.5 million of cash to fund working capital and other balance sheet increases.  Cash flow used in investing activities for the three months ended September 30, 2021 totaled $5.1 million and primarily consisted of $5.0 million used for capital expenditures. Cash used by financing activities for the three months ended September 30, 2021 was $12.6 million and consisted primarily of stock repurchases of $9.5 million, cash paid for dividends of $2.9 million, and contingent consideration payments due to the seller of the Renco business of $1.2 million.

 

29

 

During the second quarter of fiscal year 2019, we entered into a five-year Amended and Restated Credit Agreement (“credit agreement”, or “facility”) with a borrowing limit of $500 million.  The facility can be increased by an amount of up to $250 million, in accordance with specified conditions contained in the agreement.  The facility also includes a $10 million sublimit for swing line loans and a $35 million sublimit for letters of credit. 

 

Under the terms of the Credit Facility, we pay a variable rate of interest and a commitment fee on borrowed amounts as well as a commitment fee on unused amounts under the facility.  The amount of the commitment fee depends upon both the undrawn amount remaining available under the facility and the Company’s funded debt to EBITDA (as defined in the agreement) ratio at the last day of each quarter.  As our funded debt to EBITDA ratio increases, the commitment fee increases. 

 

Funds borrowed under the facility may be used for the repayment of debt, working capital, capital expenditures, acquisitions (so long as certain conditions, including a specified funded debt to EBITDA leverage ratio is maintained), and other general corporate purposes.  As of September 30, 2021, the Company used $6.1 million against the letter of credit sub-facility and had the ability to borrow $267.1 million under the facility based on our current trailing twelve-month EBITDA.  The facility contains customary representations, warranties and restrictive covenants, as well as specific financial covenants. The Company’s current financial covenants under the facility are as follows:

 

Interest Coverage Ratio - The Company is required to maintain a ratio of Earnings Before Interest and Taxes, as Adjusted (“Adjusted EBIT per the Credit Facility”), to interest expense for the trailing twelve months of at least 2.75:1.  Adjusted EBIT per the Credit Facility specifically excludes extraordinary and certain other defined items such as cash restructuring and acquisition related charges up to the lower of $20.0 million or 10% of EBITDA.  The facility also allows for unlimited non-cash charges including purchase accounting and goodwill adjustments.  At September 30, 2021, the Company’s Interest Coverage Ratio was 13.7.

 

Leverage Ratio - The Company’s ratio of funded debt to trailing twelve month Adjusted EBITDA per the Credit Facility, calculated as Adjusted EBIT per the Credit Facility plus depreciation and amortization, may not exceed 3.5:1.  Under certain circumstances in connection with a Material Acquisition (as defined in the Facility), the Facility allows for the leverage ratio to go as high as 4.0:1 for a four-fiscal quarter period.  At September 30, 2021, the Company’s Leverage Ratio was 1.24.

 

As of September 30, 2021, we had borrowings under our facility of $200.0 million. In order to manage our interest rate exposure on these borrowings, we are party to $200.0 million of active floating to fixed rate swaps.  These swaps convert our interest payments from LIBOR to a weighted average fixed rate of 1.27%.  The effective rate of interest for our outstanding borrowings, including the impact of the interest rate swaps, was 2.59%.

 

Our primary cash requirements in addition to day-to-day operating needs include interest payments, capital expenditures, acquisitions, share repurchases, and dividends.  Our primary sources of cash for these requirements are cash flows from continuing operations and borrowings under the facility.  We expect fiscal year 2022 capital spending to be between $25.0 and $30.0 million which includes amounts not spent in fiscal year 2021.  We also expect that fiscal year 2022 depreciation and amortization expense will be between $20.0 and $25.0 million and $10.0 and $15.0 million, respectively.

 

The following table sets forth our capitalization:

 

 

(In thousands)

 

September 30, 2021

   

June 30, 2021

 

Long-term debt

  $ 199,575     $ 199,490  

Less cash and cash equivalents

    (130,683 )     (136,367 )

Net debt

    68,892       63,123  

Stockholders' equity

    512,730       506,425  

Total capitalization

  $ 581,622     $ 569,548  

 

We sponsor a number of defined benefit and defined contribution retirement plans.  The U.S. pension plan is frozen for substantially all participants.  We have evaluated the current and long-term cash requirements of these plans, and our existing sources of liquidity are expected to be sufficient to cover required contributions under ERISA and other governing regulations.

 

The fair value of the Company's U.S. defined benefit pension plan assets was $209.0 million at September 30, 2021, as compared to $212.6 million at the most recent measurement date, which occurred as of June 30, 2021. The next measurement date to determine plan assets and benefit obligations will be on June 30, 2022.

 

30

 

The Company expects to pay $1.5 million in contributions to its defined benefit plans during the remainder of fiscal year 2022. Contributions of $0.1 million and $0.1 million were made during the three months ended September 30, 2021 and September 30, 2020, respectively. The Company expects to make contributions during fiscal year 2022 of $1.1 million to its U.S. defined benefit plan.  The Company expects to make contributions during fiscal year 2022 of $0.2 million and $0.3 million to its unfunded defined benefit plans in the U.S. and Germany, respectively.  Any subsequent plan contributions will depend on the results of future actuarial valuations.

 

We have an insurance program in place to fund supplemental retirement income benefits for four retired executives.  Current executives and new hires are not eligible for this program.  At September 30, 2021, the underlying policies had a cash surrender value of $19.6 million and are reported net of loans of $9.1 million for which we have the legal right of offset, these amounts are reported net on our balance sheet.

 

Other Matters

 

Inflation – Certain of our expenses, such as wages and benefits, occupancy costs, freight and equipment repair and replacement, are subject to normal inflationary pressures. Inflation for medical costs can impact both our employee benefit costs as well as our reserves for workers' compensation claims. We monitor the inflationary rate and make adjustments to reserves whenever it is deemed necessary. Our ability to control worker compensation insurance medical cost inflation is dependent upon our ability to manage claims and purchase insurance coverage to limit the maximum exposure for us. Each of our segments is subject to the effects of changing raw material costs caused by the underlying commodity price movements. We have experienced price fluctuations for a number of materials including rhodium, steel, and other metal commodities. These materials are some of the key elements in the products manufactured in these segments.  Wherever possible, we will implement price increases to offset the impact of changing prices.  The ultimate acceptance of these price increases will be impacted by our affected divisions’ respective competitors and the timing of their price increases. In general, we do not enter into purchase contracts that extend beyond one operating cycle. While Standex considers our relationship with our suppliers to be good, there can be no assurances that we will not experience any supply shortage.

 

Foreign Currency Translation – Our primary functional currencies used by our non-U.S. subsidiaries are the Euro, British Pound Sterling (Pound), Japanese (Yen), and Chinese (Yuan).

 

Defined Benefit Pension Plans – We record expenses related to these plans based upon various actuarial assumptions such as discount rates, mortality rates, and assumed rates of returns.  The Company’s pension plan is frozen for substantially all eligible U.S. employees and participants in the plan ceased accruing future benefits. 

 

Environmental Matters – To the best of our knowledge, we believe that we are presently in substantial compliance with all existing applicable environmental laws and regulations and do not anticipate any instances of non-compliance that will have a material effect on our future capital expenditures, earnings or competitive position.

 

Seasonality – We are a diversified business with generally low levels of seasonality.

 

Employee Relations – The Company has labor agreements with several union locals in the United States and several European employees belong to European trade unions. 

 

 

Critical Accounting Policies

 

The condensed consolidated financial statements include the accounts of Standex International Corporation and all of its subsidiaries. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions in certain circumstances that affect amounts reported in the accompanying condensed consolidated financial statements.  Although we believe that materially different amounts would not be reported due to the accounting policies adopted, the application of certain accounting policies involves the exercise of judgment and use of assumptions as to future uncertainties and, as a result, actual results could differ from these estimates.  Our Annual Report on Form 10-K for the year ended June 30, 2021 lists a number of accounting policies which we believe to be the most critical.

 

31

 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Risk Management

 

We are exposed to market risks from changes in interest rates, commodity prices and changes in foreign currency exchange.  To reduce these risks, we selectively use, from time to time, financial instruments and other proactive management techniques.  We have internal policies and procedures that place financial instruments under the direction of the Treasurer and restrict all derivative transactions to those intended for hedging purposes only.  The use of financial instruments for trading purposes (except for certain investments in connection with the non-qualified defined contribution plan) or speculation is strictly prohibited.  The Company has no majority-owned subsidiaries that are excluded from the consolidated financial statements.  Further, we have no interests in or relationships with any special purpose entities. 

 

Exchange Rate Risk

 

We are exposed to both transactional risk and translation risk associated with exchange rates.  The transactional risk is mitigated, in large part, by natural hedges developed with locally denominated debt service on intercompany accounts.  We also mitigate certain of our foreign currency exchange rate risks by entering into forward foreign currency contracts from time to time.  The contracts are used as a hedge against anticipated foreign cash flows, such as loan payments, customer remittances, and materials purchases, and are not used for trading or speculative purposes.  The fair values of the forward foreign currency exchange contracts are sensitive to changes in foreign currency exchange rates, as an adverse change in foreign currency exchange rates from market rates would decrease the fair value of the contracts.  However, any such losses or gains would generally be offset by corresponding gains and losses, respectively, on the related hedged asset or liability.  At September 30, 2021 the fair value, in the aggregate, of the Company’s open foreign exchange contracts was an asset of less than $0.1 million.

 

Our primary translation risk is with the Euro, British Pound Sterling, Peso, Japanese Yen and Chinese Yuan.  A hypothetical 10% appreciation or depreciation of the value of any these foreign currencies to the U.S. Dollar at September 30, 2021, would not result in a material change in our operations, financial position, or cash flows.  We hedge our most significant foreign currency translation risks primarily through cross currency swaps and other instruments, as appropriate.

 

Interest Rate Risk

 

The Company’s effective interest rate on borrowings was 2.59% at September 30, 2021.  Our interest rate exposure is limited primarily to interest rate changes on our variable rate borrowings and is mitigated by our use of interest rate swap agreements to modify our exposure to interest rate movements.  At September 30, 2021, we have $200.0 million of active floating to fixed rate swaps with terms ranging from one to four years.  These swaps convert our interest payments from LIBOR to a weighted average rate of 1.27%.  At September 30, 2021 the fair value, in the aggregate, of the Company’s interest rate swaps were liabilities of $2.6 million. A 25-basis point increase in interest rates would not change our annual interest expense as all of our outstanding debt is currently converted to fixed rate debts by means of interest rate swaps.

 

Concentration of Credit Risk

 

We have a diversified customer base. As such, the risk associated with concentration of credit risk is inherently minimized. As of September 30, 2021, no one customer accounted for more than 5% of our consolidated outstanding receivables or of our sales.

 

Commodity Prices

 

The Company is exposed to fluctuating market prices for all commodities used in its manufacturing processes.  Each of our segments is subject to the effects of changing raw material costs caused by the underlying commodity price movements.  In general, we do not enter into purchase contracts that extend beyond one operating cycle.  While Standex considers our relationship with our suppliers to be good, there can be no assurances that we will not experience any supply shortage.

 

The Engineering Technologies, Specialty Solutions, and Electronics segments are all sensitive to price increases for steel and aluminum products, other metal commodities such as rhodium and copper, and petroleum-based products.  We have experienced price fluctuations for a number of materials including rhodium, steel, and other metal commodities.  These materials are some of the key elements in the products manufactured in these segments.  Wherever possible, we will implement price increases to offset the impact of changing prices.  The ultimate acceptance of these price increases, if implemented, will be impacted by our affected divisions’ respective competitors and the timing of their price increases.

 

32

 

ITEM 4.     CONTROLS AND PROCEDURES

 

At the end of the period covered by this Report, the management of the Company, including the Chief Executive Officer and the Chief Financial Officer, evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (“Exchange Act”)). Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of September 30, 2021 in ensuring that the information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's ("SEC") rules and forms, and that such information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

 

There was no change in the Company's internal control over financial reporting during the quarterly period ended September 30, 2021 that has materially affected or is reasonably likely to materially affect the Company's internal control over financial reporting.

 

33

 

 

PART II. OTHER INFORMATION

 

Item 5. Unregistered Sales of Equity Securities and Use of Proceeds

 

(c)

The following table provides information about purchases by the Company of equity securities that are registered by the Company pursuant to Section 12 of the Exchange Act:

 

Issuer Purchases of Equity Securities(1)

Quarter Ended September 30, 2021

 

Period

 

(a) Total number of shares (or units) purchased

   

(b) Average price paid per share (or unit)

   

(c) Total number of shares (or units) purchased as part of publicly announced plans or programs

   

(d) Maximum number (or appropriate dollar value) of shares (or units) that may yet be purchased under the plans or programs

 

July 1 - July 31, 2021

    140     $ 93.13       140     $ 22,055  
                                 

August 1 - August 31, 2021

    77,601     $ 97.88       77,601       14,459  
                                 

September 1 - September 30, 2021

    19,085     $ 99.10       19,085       12,568  
                                 

Total

    96,826       98.12       96,826       12,568  

 

 

(1)

The Company has a Stock Buyback Program (the “Program”) which was originally announced on January 30, 1985 and most recently amended on April 26, 2016. Under the Program, the Company was authorized to repurchase up to an aggregate of $100 million of its shares. Under the program, purchases may be made from time to time on the open market, including through 10b5-1 trading plans, or through privately negotiated transactions, block transactions, or other techniques in accordance with prevailing market conditions and the requirements of the Securities and Exchange Commission. The Board’s authorization is open-ended and does not establish a timeframe for the purchases. The Company is not obligated to acquire a particular number of shares, and the program may be discontinued at any time at the Company’s discretion.

 

34

 

 

Item 6. Exhibits

 

 

(a)

Exhibits

 

 

31.1

Principal Executive Officer’s Certification Pursuant to Rule 13a-14(a)/15d-14(a) and Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

31.2

Principal Financial Officer’s Certification Pursuant to Rule 13a-14(a)/15d-14(a) and Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

32

Principal Executive Officer and Principal Financial Officer Certifications Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

101

The following materials from this Quarterly Report on Form 10-Q, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations, (iii) Condensed Consolidated Statements of Comprehensive Income, (iv) Condensed Consolidated Statements of Cash Flows, and (v) Notes to Unaudited Condensed Consolidated Financial Statements.

  104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

 

 

 

ALL OTHER ITEMS ARE INAPPLICABLE 

 

35

 

 

SIGNATURES

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

   

 

 

STANDEX INTERNATIONAL CORPORATION

 

 

 

Date:

November 5, 2021

/s/ ADEMIR SARCEVIC

 

 

Ademir Sarcevic

 

 

Vice President/Chief Financial Officer

 

 

(Principal Financial & Accounting Officer)

 

 

 

Date:

November 5, 2021

/s/  SEAN C. VALASHINAS

 

 

Sean C. Valashinas

    Vice President/Chief Accounting Officer/Assistant Treasurer

 

36